India Alternatives is a Mumbai-based mid-market private equity firm with a sharply defined worldview: it invests in companies positioned to become market leaders by riding three transformational themes in India — women becoming more empowered as consumers, a rising focus on health and wellness, and the confluence of financial services and technology. It is a 100% institutional fund, and describes itself as a top-performing mid-market PE player.

Sectorally, the firm hunts across consumer and consumables, healthcare and pharmaceuticals, health and wellness, fintech and enterprise tech. Its sweet spot is mid-stage growth companies — businesses past product-market fit that need growth capital to become category leaders — though it also does mid-stage venture deals and backs mature firms.

The firm's total fund size is not publicly disclosed. What is on record: its first fund launched with Rs 230 crore in commitments back in 2014, and a third fund has been reported in process with its size undisclosed. Founders should therefore read it as a serious growth-stage partner rather than a seed cheque-writer.

Its portfolio reflects the thesis precisely: Brinton Pharmaceuticals, NSDL, CIBIL (where it re-invested), Seclore, GoApptiv, Gynoveda and Kapture CX. Past board positions include HealthCare Global and Gokaldas Intimatewear — a mix that shows genuine comfort with both pharma balance sheets and consumer brands.

The firm was founded and is led by Shivani Bhasin Sachdeva (Founder & CEO), one of Indian PE's most visible women leaders — a fact that dovetails neatly with the fund's own women-as-consumers thesis. No accelerator or structured founder programme is publicly stated; this is a classic relationship-driven PE partnership, so warm introductions and banker-led processes are the way in.

The portfolio construction reveals how literally the firm takes its themes. Gynoveda (women's Ayurvedic wellness) and Kapture CX sit squarely on the women-as-empowered-consumers thesis; Brinton Pharmaceuticals and HealthCare Global on health and wellness; Seclore, GoApptiv and the CIBIL re-investment on the fintech-technology confluence. A YourStory deep-dive on the firm's exit learnings underscores a PE mindset founders should expect: rigorous value-creation plans from day one, not just capital deployment. And the firm's own history carries a signal — IIFL Wealth Management acquired a stake in India Alternatives back in 2014, an early institutional endorsement of the franchise.

Why it matters for founders

If you're running a mid-stage consumer, wellness, healthcare or fintech company doing serious revenue and looking for growth capital with a thesis-aligned partner, India Alternatives deserves a place on your target list. Come with scale, clean governance and a story that maps to their three themes — women consumers, wellness, fintech — and the conversation starts warm.